Rheumatology

Hossain T, Montesi SB, Volkmann ER, Thomson CC, Ruminjo JK, Silver RM, Ghazipura M, Raghu G. Summary for Clinicians-Clinical Practice Guideline for the Treatment of[...]

By sjmartinez • October 20, 2023

Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, Caplan L, Gore S, Grossman J, Hansen KE, Lane NE, Ma NS, Magrey[...]

By sjmartinez • October 17, 2023

Suliman YA, Campochiaro C, Hughes M, Schoones JW, Giuggioli D, Moinzadeh P, Baron M, Chung L, Ross L, Maltez N, Allanore Y, Denton CP, Distler[...]

By sjmartinez • October 13, 2023

Weisman MH. Emerging Concepts in Immune Dysregulation. Rheum Dis Clin North Am. 2023 Nov;49(4):xiii-xiv. doi: 10.1016/j.rdc.2023.08.013. Epub 2023 Sep 1. PMID: 37821204.

By sjmartinez • October 12, 2023

Montano EN, Bose M, Huo L, Tumurkhuu G, De Los Santos G, Simental B, Stotland AB, Wei J, Bairey Merz CN, Suda J, Martins G,[...]

By sjmartinez • October 7, 2023

Khanna D, Furst DE, Li JW, Meng Q, Yuan Y, Lesperance T, Peoples K, Ali F, LaMoreaux B, Taylor SD. Economic and Health Care Resource[...]

By sjmartinez • October 5, 2023

Luebker S, Frech TM, Assassi S, Skaug B, Gordon JK, Lakin K, Bernstein EJ, Luo Y, Steen VD, Shah AA, Hummers LK, Richardson C, Moore[...]

By sjmartinez • October 5, 2023

P Singh R, S Bischoff D, S Singh S, H Hahn B. Peptide-based immunotherapy in lupus: Where are we now? Rheumatol Immunol Res. 2023 Sep[...]

By sjmartinez • October 2, 2023

La Cava A. Low-dose interleukin-2 therapy in systemic lupus erythematosus. Rheumatol Immunol Res. 2023 Sep 27;4(3):150-156. doi: 10.2478/rir-2023-0021. PMID: 37781677; PMCID: PMC10538619.

By sjmartinez • October 2, 2023

Campochiaro C, Suliman YA, Hughes M, Schoones JW, Giuggioli D, Moinzadeh P, Baron M, Chung L, Ross L, Maltez N, Allanore Y, Denton CP, Distler[...]

By sjmartinez • October 2, 2023